These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27976560)

  • 1. Evaluation of the removal reasons of totally implantable venous devices in children: a retrospective study.
    Kılıç S; Soyer T; Karnak İ; Çiftçi AÖ; Tanyel FC; Şenocak ME
    Turk J Pediatr; 2016; 58(2):187-194. PubMed ID: 27976560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications and conservative treatment of totally implantable venous access devices in children with cancer.
    Yazıcı N; Akyüz C; Yalçın B; Varan A; Kutluk T; Büyükpamukçu M
    Turk J Pediatr; 2013; 55(2):164-71. PubMed ID: 24192676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
    J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
    Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
    Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of port-a-cath in cancer patients: a single-center experience.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Zahid KF; Furrukh M; Burney IA; Al-Moundhri MS
    J Infect Dev Ctries; 2014 Nov; 8(11):1476-82. PubMed ID: 25390061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of totally implantable venous-access port-related infections.
    Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
    Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous implantation of peripherally inserted totally implantable venous access systems in the forearm in adolescent patients.
    Augustin AM; Kertels O; Wiegering V; Thurner A; Kickuth R
    Pediatr Radiol; 2022 Jul; 52(8):1550-1558. PubMed ID: 35368211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radiologically implanted central venous port systems explanted due to complications.
    Teichgräber UK; Kausche S; Nagel SN
    J Vasc Access; 2011; 12(4):306-12. PubMed ID: 21534232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of retained Port-A-Cath fragments during removal.
    Aworanti OM; Linnane N; Tareen F; Mortell A
    Pediatr Surg Int; 2017 Jul; 33(7):777-781. PubMed ID: 28584903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
    Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
    Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for infectious and noninfectious complications of totally implantable venous catheters in cancer patients.
    Zerati AE; Figueredo TR; de Moraes RD; da Cruz AM; da Motta-Leal Filho JM; Freire MP; Wolosker N; de Luccia N
    J Vasc Surg Venous Lymphat Disord; 2016 Apr; 4(2):200-5. PubMed ID: 26993868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors of infectious complications related to implantable venous-access ports.
    Shim J; Seo TS; Song MG; Cha IH; Kim JS; Choi CW; Seo JH; Oh SC
    Korean J Radiol; 2014; 15(4):494-500. PubMed ID: 25053910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.